Previous 10 | Next 10 |
TORONTO, ON / ACCESSWIRE / August 12, 2020 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, today reported financial results for the three and nine months ended June 30, 2020 and provided an update on its business. During the quarter, Edesa received Canadian ...
Gainers: Sonnet BioTherapeutics (NASDAQ: SONN ) +97% . More news on: Sonnet BioTherapeutics Holdings, Inc., Zion Oil & Gas, Inc., Fluidigm Corporation, Stocks on the move, , Read more ...
Taoping (NASDAQ: TAOP ) -23% . More news on: Taoping Inc., Precipio, Inc., Socket Mobile, Inc., Stocks on the move, , Read more ...
Gainers: Taoping (NASDAQ: TAOP ) +492% . More news on: Taoping Inc., Edesa Biotech, Inc., DIRTT Environmental Solutions Ltd., Stocks on the move, , Read more ...
FSD Pharma (NASDAQ: HUGE ) +130% . on decision to surrender health Canada licenses for subsidiary FV Pharma. More news on: FSD Pharma Inc., Kandi Technologies Group, Inc., Edesa Biotech, Inc., Stocks on the move, , Read more ...
Edesa Biotech (NASDAQ: EDSA ) soars 66% premarket after filing an IND application with the FDA to initiate a Phase 2/3 clinical study of EB05, for the treatment of hospitalized COVID-19 patients. More news on: Edesa Biotech, Inc., Healthcare stocks news, Stocks on the ...
TORONTO, ON / ACCESSWIRE / July 30, 2020 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 2/Phase 3 clinical study of its inv...
Urban One (NASDAQ: UONE ) -24% . More news on: Urban One, Inc., The9 Limited, China HGS Real Estate Inc., Stocks on the move, , Read more ...
Edesa Biotech (NASDAQ: EDSA ) +218% on launch of COVID-19 study in Canada. More news on: Edesa Biotech, Inc., Brickell Biotech, Inc., BioHiTech Global, Inc., Stocks on the move, , Read more ...
Are These Penny Stocks To Buy Or Avoid This Week? When it comes to penny stocks , things can change at a moment’s notice. We saw this first-hand over the last few days. On Friday, there were several stocks under $5 that finished the week strong. But if you were to look at them on Monda...
News, Short Squeeze, Breakout and More Instantly...
This Phase 2 clinical study will evaluate paridiprubart (EB05) in hospitalized patients with acute respiratory distress syndrome (ARDS) due to a variety of causes. This BARDA-funded project is expected to complement Edesa's ongoing drug development activities in COVID-19 ARDS. Paridipru...
TORONTO, ON / ACCESSWIRE / May 10, 2024 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and six months ended March 31, 2024 and provid...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...